GLOBALFOUNDRIES, IBM, Intermolecular Collaborate to Speed Advanced Logic Development
SAN JOSE, Calif., Oct. 2, 2012 (GLOBE NEWSWIRE): Intermolecular, Inc. today announced that GLOBALFOUNDRIES and IBM will leverage Intermolecular's High Productivity Combinatorial (HPC™) technology, as the companies work to speed development of manufacturing technologies down to the 10nm node.
Intermolecular’s combinatorial technology allows many more tests to be done using a single wafer. This enables experimental data to be generated and analyzed with significantly greater speed and efficiency than a traditional development line, accelerating innovation in materials, processes, and device architectures.
“IBM and, GLOBALFOUNDRIES are committed to pushing forward the leading-edge of IC logic manufacturing with new materials and device structures,” said Gary Patton, VP Semiconductor Research for IBM. “Intermolecular’s HPC technology will help to more rapidly explore materials and processing options for advanced logic manufacturing.”
“We are pleased that IBM and GLOBALFOUNDRIES will be able to leverage our HPC platform to address GLOBALFOUNDRIES’ high-volume manufacturing R&D challenges,” said David Lazovsky, Intermolecular president and CEO.
“Our business model is built on collaboration, both in customer engagements and technology development,” commented David Bennett, vice president of alliances for GLOBALFOUNDRIES. “Collaborating with Intermolecular has strengthened our R&D pipeline and improved R&D efficiency.”
Intermolecular’s mission is to drive our customers’ success by transforming R&D and accelerating innovation in markets that derive competitive advantage from the interaction of materials science, processes, integration and device architecture.
Statements made in this press release that are not statements of historical fact are forward-looking statements. Forward-looking statements are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release relate, but are not limited, to the Company’s expectations for any incremental revenue related to the technology that is being leveraged. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from expectations, including but not limited to risks detailed from time to time under the heading "Risk Factors" in the Company's report on Form 10-K for fiscal year 2011, and its subsequent reports on Form 10-Q for fiscal year 2012. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
About Intermolecular, Inc.
Intermolecular® has pioneered a proprietary approach to accelerate research and development, innovation, and time-to-market for the semiconductor and clean energy industries. The approach consists of its proprietary HPCTM platform, coupled with its multi-disciplinary team. Through paid collaborative development programs (CDPs) with its customers, Intermolecular develops proprietary technology and intellectual property for its customers focused on advanced materials, processes, integration and device architectures. Founded in 2004, Intermolecular is based in San Jose, California. “Intermolecular” and the Intermolecular logo are registered trademarks; and “HPC” is a trademark of Intermolecular, Inc.; all rights reserved. Learn more at www.intermolecular.com.
Ed Korczynski, Intermolecular
Marketing Communications Director
Investor Relations Contact
Gary Hsueh, Intermolecular
Sr. Director of Corporate Development and Investor Relations